Home

Featured

ODA-ASCO 2024-Arlene Siefker-Radtke, MD_960x800
ODA-ASCO 2024-Daniel Rubin, PharmD_960x800
ODA-ASCO 2024-Andrea Roman, PharmD, BCOP_960x800 (1)
ODA-ASCO 2024-Lakshmi Nayak, MD_960x800
ODA-ASCO 2024-Ahsan Arozullah, MD, MPH_960x800
ODA-ASCO 2024-Arlene Siefker-Radtke, MD_960x800
ODA-ASCO 2024-Daniel Rubin, PharmD_960x800
ODA-ASCO 2024-Andrea Roman, PharmD, BCOP_960x800 (1)
2024-Best of ASCO 2024-Expert Panel_960x800
ODA-Expert Perspectives-Brain Tumor Awareness Month_960x800
b2ap3_large_Video-2024-AML-Awareness-Day_960x800
OncData-FDA Article Image-Template_960x800 (1)
OncData-FDA Article Image-Template_960x800
Fellows Forum-Blog Series-June 2024-Article Image_960x800
ODA-ASCO 2024-Arlene Siefker-Radtke, MD_960x800
ODA-ASCO 2024-Daniel Rubin, PharmD_960x800
ODA-ASCO 2024-Andrea Roman, PharmD, BCOP_960x800 (1)
Fellows Forum-Thejal Srikumar, MD_960x800
2024-Best of ASCO 2024-Expert Panel_960x800
Fellows Forum-Sharafeldin and Haque_960x800
OncData Article-223VHL_960x800
b2ap3_large_Podcast-Expert-Perspectives-Episode-3-Genetics-Counseling_960x800
b2ap3_large_Video-Expert-Perspectives-Episode-2-Genetics-Counseling_960x800
ODA-ONS Congress 2024-Lauren Ghazal, PhD, FNP-BC_960x800
ODA-ONS Congress 2024-Kelly Tan, PhD, RN_960x800
Dr. Stephen Freedland and Dr. Farnoosh Nik-Ahd discuss their study on the risk of prostate cancer in transgender women.
b2ap3_large_From-the-Editor-Case-in-Contrasts_960x800
Dr. Rahul Banerjee, Editor in Chief, pens a 2024 kickoff message for Oncology Data Advisor readers.
Dr. Rahul Banerjee and Dr. Thomas Abrams share messages for OncData readers as they pass the Editor in Chief baton.

Listen to the Podcast